Neuronetics Inc. (STIM)
Neuronetics Inc. (STIM) Stock Price, Analysis & Data
| Bid | n/a |
| Market Cap | 240.02M |
| Revenue (ttm) | 155.1M |
| Net Income (ttm) | -30.43M |
| Beta | 1.12 |
| EPS (ttm) | -0.41 |
| PE Ratio (ttm) | n/a |
| Forward PE | -9.26 |
| P/B (ttm) | 13.46 |
| P/S (ttm) | 1.55 |
| Earnings Date | Nov 3, 2026 |
| Ask | n/a |
| Volume | 1,452,144 |
| Avg. Volume (20D) | 2,391,288 |
| Open | 3.22 |
| Previous Close | 3.27 |
| Day's Range | 3.10 - 3.33 |
| 52-Week Range | 0.80 - 3.71 |
| Analyst | Strong Buy |
| Price Target | 4 (26.98%) |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About STIM
Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally. The company provides NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces ele...
Financial Performance
In 2025, Neuronetics's revenue was 149.16M, an increase of 99.17% compared to the previous year's 74.89M. Earnings were -39M, a decrease of -10.78%.
Financial StatementsAnalyst Forecast
According to 4 analyst ratings, the average rating for STIM stock is "Strong Buy". The 12-month stock price forecast is 4, which is upside of 26.98% from the latest price.
Stock ForecastsEarnings Surprise
Analysts project revenue of ... Upgrade
